Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Wieand

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|February 5, 2002
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitisIgor Dvorchik, Michael Subotin, A Jake Demetris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
Cancer|February 6, 2003
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinomaMartin Kunkel, Torsten E Reichert, Peter Benz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
Cancer|September 5, 2002
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690John M Kirkwood, Thomas Richards, Hassane M Zarour, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2005
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-upJose A Seixas-Silva, Thomas Richards, Fadlo R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative studyCarmen J Allegra, Soon Paik, Linda H Colangelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft modelXin Zhang, Zhuo Georgia Chen, Mi Sun Choe, et al.
American Journal of Clinical Oncology|October 4, 2005
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancerKhalid Matin, Samuel A Jacobs, Thomas Richards, et al.
Clinical Colorectal Cancer|October 4, 2005
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research ProgramJames N Atkins, Samuel A Jacobs, H Samuel Wieand, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|February 5, 2002
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitisIgor Dvorchik, Michael Subotin, A Jake Demetris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
Cancer|February 6, 2003
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinomaMartin Kunkel, Torsten E Reichert, Peter Benz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
Cancer|September 5, 2002
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690John M Kirkwood, Thomas Richards, Hassane M Zarour, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2005
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-upJose A Seixas-Silva, Thomas Richards, Fadlo R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative studyCarmen J Allegra, Soon Paik, Linda H Colangelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft modelXin Zhang, Zhuo Georgia Chen, Mi Sun Choe, et al.
American Journal of Clinical Oncology|October 4, 2005
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancerKhalid Matin, Samuel A Jacobs, Thomas Richards, et al.
Clinical Colorectal Cancer|October 4, 2005
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research ProgramJames N Atkins, Samuel A Jacobs, H Samuel Wieand, et al.
Pageof 3